Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.60 +0.09 (+17.65%)
As of 06/25/2025 02:15 PM Eastern

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.60
$0.60
50-Day Range
$0.43
$0.60
52-Week Range
$0.31
$0.67
Volume
7,000 shs
Average Volume
7,132 shs
Market Capitalization
$13.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Pharma-Bio Serv Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

PBSV MarketRank™: 

Pharma-Bio Serv scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pharma-Bio Serv.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pharma-Bio Serv is -60.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pharma-Bio Serv is -60.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Pharma-Bio Serv has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pharma-Bio Serv's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Pharma-Bio Serv has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharma-Bio Serv has recently increased by 50.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pharma-Bio Serv does not currently pay a dividend.

  • Dividend Growth

    Pharma-Bio Serv does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of Pharma-Bio Serv has been sold short.
  • Short Interest Ratio / Days to Cover

    Pharma-Bio Serv has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pharma-Bio Serv has recently increased by 50.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pharma-Bio Serv has a news sentiment score of -0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.94 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Pharma-Bio Serv this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.60% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Pharma-Bio Serv's insider trading history.
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Pharma-Bio Serv, Inc. - Seeking Alpha
OTC:PBSV Financials | Pharma-Bio Serv Inc - Investing.com
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Pharma-Bio Serv (OTCMKTS:PBSV) and Gartner (NYSE:IT) Critical Review
PBSV Decisions Paying Off
PBSV Returns to Growth
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 at the start of the year. Since then, PBSV shares have increased by 9.1% and is now trading at $0.60.
View the best growth stocks for 2025 here
.

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) announced its quarterly earnings results on Monday, March, 17th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.02 by $0.35. The company earned $2.47 million during the quarter, compared to analysts' expectations of $2.70 million. Pharma-Bio Serv had a negative net margin of 1.96% and a negative trailing twelve-month return on equity of 1.47%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Last Earnings
3/17/2025
Today
6/27/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
Employees
185
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
5.45
P/E Growth
N/A
Net Income
-$780 thousand
Pretax Margin
-2.01%

Debt

Sales & Book Value

Annual Sales
$9.51 million
Price / Cash Flow
N/A
Book Value
$0.53 per share
Price / Book
1.13

Miscellaneous

Free Float
20,043,000
Market Cap
$13.76 million
Optionable
Not Optionable
Beta
0.68

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners